Researchers will test human embryos left over from IVF treatment to find those that are genetically programmed to develop into the "O-negative" blood group, which is the
universal donor group whose blood can be transfused into anyone without fear of tissue rejection.
In the study, researchers will test human embryos left over from IVF treatment to find those that are genetically programmed to develop into the "O-negative" blood group, which is the
universal donor group whose blood can be transfused into anyone without fear of tissue rejection.
Many babies are treated with O Negative or
universal donor blood, so-called because it can be safely given to anyone.
A short video describing Medistem and its new
universal donor stem cell product, the Endometrial Regenerative Cell (ERC) can be found at http://youtu.
People don't realise that their donation could help three people and one donation of O negative or
universal donor blood can save eight premature babies.
Bone marrow stromal cells as
universal donor cells' for myocardial regeneration therapy
Companies to Develop
Universal Donor Chondrocyte Cell Treatments
We currently have less than one day's supply of O-positive and O- negative blood, the
universal donor group often used in emergencies,'' said Christine Hobley, donor recruitment representative for Santa Clarita.
Donations typically fall off during the holidays, but many regular donors have been sick and unable to give blood, which has left the American Red Cross Los Angeles chapter 500 units short of type O blood, the
universal donor type.
OTCQB: MEDS), a pioneer in the development of Endometrial Regenerative Cells ("ERC" or "ERCs"),
universal donor adult-derived stem cells with properties uniquely suited for therapeutic use with Intrexon's existing suite of synthetic biology technologies.
In California, low supplies of blood - especially O-negative, the
universal donor - can be life-threatening for many, especially in the event of a natural disaster or major catastrophe.
With these new SBIR grants, Taiga has now received peer-reviewed validation across all four of its primary technology platforms: therapeutic antibodies against difficult protein targets, an immune response enhancer for vaccines to infectious diseases and cancer,
universal donor blood stem cells, and blood cell expansion technology," said Brian Turner, Ph.
